|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.10 EUR | +0.12% |
|
-3.05% | +36.22% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
EPS & Dividend: Ipsen
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.532 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.95% | 0.95% | 1.02% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.11 | 11.37 | 11.36 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.7% | 13.5% | 14.6% |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 161.90 | 161.90 | 161.90 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Ipsen
| 03/06/2026 | Ex-dividend date - 1.6 EUR | 07:00 |
Upcoming Events: Ipsen
| 01/10/2026 | Information meeting | Day | |
| 22/10/2026 | Sales and Revenue Release | Q3 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.95% | 0.95% | 13.37x | 2.39x | 2.65x | |
| 0.57% | 0.64% | 33.78x | 20.73x | 12.37x | |
| 2.09% | 2.19% | 28.59x | - | - | |
| 2.84% | 2.96% | 32.06x | 362.92x | 7.3x | |
| 2.74% | 2.8% | 20.32x | 7.27x | 4.82x | |
| 2.84% | 2.96% | 21.87x | 6.16x | 5.66x | |
| 2.09% | 2.21% | 20.44x | 4.59x | 4.22x | |
| 2.49% | 2.63% | 25.38x | 17.74x | 6.71x | |
| 3.83% | 3.79% | 13.28x | 5.63x | 4.8x | |
| 2.52% | 2.61% | -40.65x | 8.08x | 5.84x | |
| Average | 2.29% | 2.37% | 16.84x | 48.39x | 6.04x | |
| Weighted average by Cap. | 1.99% | 2.08% | 24.38x | 63.69x | 8.08x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
